GI
MRVI icon

GAMMA Investing’s Maravai LifeSciences MRVI Stock Holding History

GAMMA Investing’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.52K Buy
884
+52
+6% +$224 ﹤0.01% 3424
2026
Q1 		$2.35K Buy
832
+687
+474% +$2.33K ﹤0.01% 3619
2025
Q4 		$471 Buy
+145
New +$488 ﹤0.01% 3923
2025
Q1 		– Sell
-2,774
Closed -$15.1K – 3854
2024
Q4 		$15.1K Buy
2,774
+593
+27% +$3.81K ﹤0.01% 2408
2024
Q3 		$18.1K Sell
2,181
-1,404
-39% -$12.1K ﹤0.01% 2164
2024
Q2 		$25.7K Buy
3,585
+2,711
+310% +$23.4K ﹤0.01% 1680
2024
Q1 		$7.58K Buy
874
+825
+1,684% +$5.58K ﹤0.01% 2201
2023
Q4 		$284 Buy
+49
New +$317 ﹤0.01% 3079

Other funds holding MRVI

DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

GAMMA Investing's MRVI Position: Q2 2026 in Review

GAMMA Investing increased its Maravai LifeSciences (MRVI) stake by 6.3% in Q2 2026, buying an estimated $224 and bringing the position to 884 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #3424.

GAMMA Investing first reported a position in MRVI in Q4 2023 and has held it in 8 quarters since. The position peaked at $25.7K in Q2 2024. 4 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • GAMMA Investing held 884 shares of Maravai LifeSciences worth $5.52K as of Q2 2026.
  • GAMMA Investing bought 52 Maravai LifeSciences shares in Q2 2026, an estimated $224.
  • Maravai LifeSciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3424 holding.
  • GAMMA Investing first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 8 quarters since.
  • GAMMA Investing's Maravai LifeSciences position peaked at $25.7K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.